Last reviewed · How we verify
NCT03890094
Safety and Efficacy of Sufentanil Combined With Midazolam in Bronchoscopy Under Conscious Sedation: Retrospective Study
trial testing Sufentanil in Bronchoscopy in 11,158 participants. Completed in 30 May 2018.
30 March 2018
Quick facts
| Lead sponsor | Guangzhou Institute of Respiratory Disease |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 11,158 |
| Start date | 1 January 2018 |
| Primary completion | 30 March 2018 |
| Estimated completion | 30 May 2018 |
| Sites | 1 location across China |
Drugs / interventions tested
- Sufentanil (SUFENTANIL) — full drug profile →
Conditions studied
- Bronchoscopy — all drugs for Bronchoscopy →
- Sedation — all drugs for Sedation →
Sponsor
Guangzhou Institute of Respiratory Disease
Who can join
18 and older, any sex, with Bronchoscopy or Sedation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to determine the safety and efficacy of sufentanil combined with midazolam in bronchoscopy under conscious sedation. A retrospective analysis was conducted on all patients undergoing bronchoscopy applying sufentanil and midazolam under conscious sedation in the First Affiliated Hospital of Guangzhou Medical University from September 2013 to July 2017.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Safety and efficacy of sufentanil combined with midazolam in bronchoscopy under conscious sedation: retrospective study of 11,158 cases.
Yao Y, Su Z, Chen Y, Ye Y, et al · · 2019 · cited 10× · PMID 31737295 · DOI 10.21037/jtd.2019.10.03
Verify or expand the search:
- PubMed search for NCT03890094
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sufentanil
Trials testing the same drug.
- NCT07386626 — Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection · NA · recruiting
- NCT07479446 — Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery · NA · not yet recruiting
- NCT07323043 — Comparison of Cough Response Between Tegilidine and Sufentanil as Pre-induction Agents in General Anesthesia · NA · recruiting
- NCT07018375 — The Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain After Video-Assisted Th · Phase 4 · not yet recruiting
- NCT07376577 — Efficacy and Safety of Anricofen Combined With Ciprofol for Deep Sedation in Elderly Patients Undergoing ERCP · NA · not yet recruiting
Other recruiting trials for Bronchoscopy
Currently open trials in the same condition.
- NCT07368829 — AI-Driven Autonomous Registration in Robotic Bronchoscopy · NA · recruiting
- NCT07517926 — Chewing Gum and Cold Gargle on Post-Bronchoscopy Symptoms · NA · recruiting
- NCT07006311 — Robotic-assisted Bronchoscopy Under Moderate Sedation With Propofol · NA · recruiting
- NCT07057648 — Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea · recruiting
- NCT06953414 — Classification and Prediction of Difficult Awake Tracheal Intubation With Flexible Bronchoscopes · recruiting
Other Guangzhou Institute of Respiratory Disease trials
Trials by the same sponsor.
- NCT07092137 — Nano-crystalline Megestrol Acetate for Anorexia-Cachexia Syndrome in Advanced Lung Cancer · Phase 2 · not yet recruiting
- NCT06909383 — Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Can · Phase 2 · not yet recruiting
- NCT07005999 — Interventional Ablation for Early-stage Lung Cancer · active not recruiting
- NCT06739928 — Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC · Phase 2 · recruiting
- NCT06715956 — Observational Study of Sputum Inflammation Phenotypes and Clinical Outcomes in Non-Cystic Fibrosis Bronchiectasis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03890094 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangzhou Institute of Respiratory Disease
- Last refreshed: 2 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03890094.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing